IMPROVEMENT IN METABOLIC RISK FACTORS FOR CVD – (05-08-05)By
Effect of orlistat on cardiovascular disease risk in obese adults
Just so you know–it wasn’t me that designated April/May as “beat up the pharmaceuticals for obesity” months.
This study found improvements in several metabolic risk factors for CVD, but not enough to lower 10-year risk assessment. Interestingly, although the patients on orlistat had lower total cholesterol, none reduced their cholesterol lowering meds. I can practically guarantee that lifestyle changes geared towards a healthy body composition will definitely lower a patient’s need for cholesterol lowering drugs.
Do you like what you’ve read here? Would you like to read more? Join the Rantings!
Join now and receive Dr. Bogash’s Lifestyle Recommendations ebook free!
ABOUT THE AUTHOR
Since acquiring a passion for how the body works in chiropractic school, I have continued to indulge this desire by reading some 120 peer reviewed medical journals per month. I’m always learning more about how to help people avoid chronic diseases like diabetes, heart disease, dementia, osteoporosis, obesity and cancer, and pass along this information in my blog. There are currently almost 2,000 posts cataloged on almost every health topic imaginable. Click Here for more bio information